Am I Eligible for a Mesothelioma Clinical Trial?

Common Eligibility Criteria

Every clinical trial has inclusion criteria (requirements you must meet) and exclusion criteria (conditions that disqualify you). According to the National Cancer Institute, these criteria exist to ensure patient safety and the scientific validity of the study results. While each trial has unique requirements, several criteria are common across most mesothelioma studies.

A confirmed mesothelioma diagnosis through biopsy and pathology review is universally required. Most trials specify the mesothelioma type (pleural, peritoneal, or both), cell type (epithelioid, sarcomatoid, or biphasic), and sometimes the stage. Some trials focus on newly diagnosed patients while others accept those who have already undergone treatment.

Performance Status and Health

Trials use performance status scales — most commonly the ECOG (Eastern Cooperative Oncology Group) scale — to assess a patient's general health and ability to tolerate treatment. Most trials require an ECOG score of 0 to 2, meaning you are capable of self-care and are up and about more than 50% of waking hours. Patients who are bedridden or require constant assistance (ECOG 3–4) are typically excluded for safety reasons.

Adequate organ function is another standard requirement. Blood tests measuring kidney function (creatinine), liver function (AST, ALT, bilirubin), and bone marrow function (blood counts) must fall within ranges specified by the trial protocol. These tests ensure your body can safely process the experimental treatment.

Treatment History Considerations

Prior treatment history significantly affects eligibility. First-line trials typically seek patients who have not received previous chemotherapy for mesothelioma. Second-line trials require that patients have received and progressed on at least one prior therapy. Some trials exclude patients who have received specific drugs or treatments to avoid confounding results.

A washout period — a specified time since your last treatment — is usually required before joining a new trial. This allows the effects of previous treatment to clear your system. Common washout periods range from 2 to 6 weeks depending on the previous and experimental treatments. Discuss timing with your oncologist.

How to Determine Your Eligibility

The most efficient approach is to work with your oncologist, who can review trial eligibility criteria against your specific medical profile. Clinical trial coordinators at mesothelioma treatment centers can also screen you for multiple trials simultaneously. Do not self-exclude based on a preliminary reading of eligibility criteria — borderline cases are often considered individually.

If you are denied entry to one trial, others may still be available. Eligibility criteria vary significantly between studies, and new trials open regularly. Meanwhile, pursuing legal compensation for asbestos exposure is independent of clinical trial participation.